Lisa Villarroel, MD MPH Medical Director, Division of Public Health Preparedness Arizona Department of Health Services.
|
|
|
- Adam Willis
- 5 years ago
- Views:
Transcription
1 Lisa Villarroel, MD MPH Medical Director, Division of Public Health Preparedness Arizona Department of Health Services Disclosures: None 1
2 PRIMARY Fitzgerald TJ, Cleveland P, Johnson RC et al: Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells. J Bacteriol 130:1333, PRIMARY CDC Library 2
3 PRIMARY CDC PHIL PRIMARY SECONDARY CDC PHIL
4 PRIMARY SECONDARY CDC Library PRIMARY SECONDARY CDC Picture Cards 4
5 PRIMARY SECONDARY CDC Library PRIMARY SECONDARY EARLY LATENT 5
6 PRIMARY SECONDARY EARLY LATENT LATE LATENT PRIMARY SECONDARY EARLY LATENT LATE LATENT 6
7 EARLY LATE CDC clinical slides 7
8 NEUROSYPHILIS CAN OCCUR AT EARLY LATE NEUROSYPHILIS CAN OCCUR AT TRANSMISSION TO THE FETUS CAN OCCUR AT. 8
9 TRANSMISSION TO THE FETUS CAN OCCUR AT. CDC clinical slides TRANSMISSION TO THE FETUS CAN OCCUR AT. CDC PHIL
10 TRANSMISSION TO THE FETUS CAN OCCUR AT. EARLY LATE NEUROSYPHILIS CAN OCCUR AT TRANSMISSION TO THE FETUS CAN OCCUR AT. 10
11 EARLY LATE 11
12 Credit: National Archives. EARLY LATE 12
13 EARLY LATE NEUROSYPHILIS CAN OCCUR AT TRANSMISSION TO THE FETUS CAN OCCUR AT. 13
14 RATE 14
15 PRIMARY & SECONDARY SYPHILIS CASES MEN WHO HAVE SEX WITH MEN MEN WHO HAVE SEX WITH WOMEN PRIMARY & SECONDARY SYPHILIS CASES MEN WHO HAVE SEX WITH MEN MEN WHO HAVE SEX WITH WOMEN WOMEN 15
16 PRIMARY & SECONDARY SYPHILIS RATE / 100,000 ARIZONA U.S PRIMARY & SECONDARY SYPHILIS CASES IN ARIZONA
17 PRIMARY & SECONDARY SYPHILIS RATE / 100,000 BLACK (24) AMERICAN INDIAN HISPANIC WHITE ASIAN (4.5) CONGENITAL SYPHILIS CASES & RATES / 100,00 30 ARIZONA 20 CASE RATE U.S. CASE RATE
18 18
19 SYMPTOM RECOGNITION PRIMARY SECONDARY EARLY LATENT LATE LATENT SYMPTOM RECOGNITION 19
20 PRIMARY SECONDARY EARLY LATENT LATE LATENT SYMPTOM RECOGNITION CDC Syphilis Images PRIMARY SECONDARY EARLY LATENT LATE LATENT SYMPTOM RECOGNITION Joe Engelman, SF City Clinic 20
21 SYMPTOM RECOGNITION EARLY LATE SYMPTOM RECOGNITION CDC Syphilis Images 21
22 SYMPTOM RECOGNITION CDC Syphilis Images EARLY LATE NEUROSYPHILIS CAN OCCUR AT Review of Ophthal,,
23 NEUROSYPHILIS CAN OCCUR AT Review of Ophthal,, 2008 EARLY LATE SCREEN 23
24 EARLY LATE 24
25 EARLY LATE LABORATORY TESTING 25
26 NONTREPONEMAL TESTS RPR, VDRL TREPONEMAL TESTS TPPA, FTA-ABS CIA, EIA (NEW) TIME OF INFECTION WEEKS TIME POST-INFECTION YEARS 26
27 TREPONEMAL TESTS (TPPA, FTA-ABS) TIME OF INFECTION WEEKS TIME POST-INFECTION YEARS TREPONEMAL TESTS (TPPA, FTA-ABS) UNTREATED NONTREPONEMAL TESTS (RPR, VDRL) TREATED TIME OF INFECTION WEEKS TIME POST-INFECTION YEARS 27
28 NONTREPONEMAL TESTS RPR, VDRL FOLLOWS RESPONSE TO TREATMENT 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:
29 2-FOLD CHANGE 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1: FOLD CHANGE 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1: FOLD CHANGE [SIGNIFICANT] 29
30 NONTREPONEMAL TESTS RPR, VDRL FOLLOWS RESPONSE TO TREATMENT CAN VARY DAILY EARLY LATE NONTREPONEMAL TESTS RPR, VDRL FOLLOWS RESPONSE TO TREATMENT CAN VARY DAILY ARE FALSE POSITIVES 30
31 NONTREPONEMAL TESTS RPR, VDRL FOLLOWS RESPONSE TO TREATMENT CAN VARY DAILY ARE FALSE POSITIVES ARE RARE FALSE NEGATIVES EARLY LATE TREPONEMAL TESTS TPPA, FTA-ABS, CIA/EIA. 31
32 TREPONEMAL TESTS TPPA, FTA-ABS, CIA/EIA GOOD, EARLY PERFORMANCE. REACTIVITY PERSISTS OVER TIME EARLY LATE TREPONEMAL TESTS TPPA, FTA-ABS, CIA/EIA GOOD, EARLY PERFORMANCE. REACTIVITY PERSISTS OVER TIME LESS FALSE POSITIVES (FTA, EIA MAIN PROBLEM) 32
33 NONTREPONEMAL TESTS RPR, VDRL TREPONEMAL TESTS TPPA, FTA-ABS, CIA/EIA. EARLY LATE NONTREPONEMAL TESTS RPR, VDRL TREPONEMAL TESTS TPPA, FTA-ABS, CIA/EIA. 33
34 TRADITIONAL NONTREPONEMAL (RPR) Am J OB and GYN, April 2017 TRADITIONAL NONTREPONEMAL (RPR) Am J OB and GYN, April
35 TRADITIONAL NONTREPONEMAL (RPR) TREPONEMAL Am J OB and GYN, April 2017 TRADITIONAL NONTREPONEMAL (RPR) TREPONEMAL Am J OB and GYN, April
36 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL Am J OB and GYN, April 2017 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL Am J OB and GYN, April
37 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL NONTREPONEMAL (RPR) Am J OB and GYN, April 2017 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL NONTREPONEMAL (RPR) TREPONEMAL (TPPA) Am J OB and GYN, April
38 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL NONTREPONEMAL (RPR) TREPONEMAL (TPPA) Am J OB and GYN, April 2017 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL NONTREPONEMAL (RPR) TREPONEMAL (TPPA) Am J OB and GYN, April
39 TRADITIONAL NONTREPONEMAL (RPR) REVERSE TREPONEMAL (EIA/CIA) TREPONEMAL NONTREPONEMAL (RPR) TREPONEMAL (TPPA) Am J OB and GYN, April 2017 EARLY LATE STAGING 39
40 SYMPTOMS = PRIMARY / SECONDARY STAGES EARLY LATE NO SYMPTOMS = LATENT STAGES 40
41 NO SYMPTOMS = LATENT STAGES EARLY IF IN PAST YEAR NEG SYPHILIS SEROLOGY LATE IF IN PAST YEAR (NONE OF THOSE) KNOWN CONTACT TO EARLY CASE OF SYPHILIS HISTORY OF SYMPTOMS SUSTAINED 4x INCREASE ONLY POSSIBLE EXPOSURE EARLY LATE 41
42 SYMPTOM RECOGNITION 42
43 SYMPTOM RECOGNITION EMPIRICALLY TREAT EARLY LATE SYMPTOM RECOGNITION EMPIRICALLY TREAT PARTNERS WITHIN 90 DAYS EMPIRICALLY TREAT 43
44 EARLY LATE TREATMENT NEEDED? GET HISTORY 44
45 PRIMARY SECONDARY EARLY LATENT LATE LATENT SYMPTOM RECOGNITION EMPIRICALLY TREAT TREATMENT NEEDED? GET HISTORY PARTNERS WITHIN 90 DAYS EMPIRICALLY TREAT EARLY LATE BENZATHINE PENICILLIN G 2.4 MILLION UNITS IM x 1, ONCE 45
46 BENZATHINE PENICILLIN G 2.4 MILLION UNITS IM x 1, ONCE BENZATHINE PENICILLIN G 2.4 MILLION UNITS IM x 3, Q WEEK EARLY LATE DAY OF TREATMENT CHECKLIST 46
47 DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). EARLY LATE DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). RPR 1:1024 RPR 1:256 [NOT CHECKED] RPR 1:256 DAY OF INITIAL LAB TEST DAY OF TREATMENT DAY OF FOLLOW UP 47
48 DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). WARN ABOUT JARISCH-HERXHEIMER. EARLY LATE DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). WARN ABOUT JARISCH-HERXHEIMER. COUNSEL NO SEX x 1 WEEK. 48
49 DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). WARN ABOUT JARISCH-HERXHEIMER. COUNSEL NO SEX x 1 WEEK. ADVISE THAT ALL PARTNERS BE EVALUATED. EARLY LATE DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). WARN ABOUT JARISCH-HERXHEIMER. COUNSEL NO SEX x 1 WEEK. ADVISE THAT ALL PARTNERS BE EVALUATED. CONFIRM HAS BEEN TESTED FOR HIV. 49
50 DAY OF TREATMENT CHECKLIST GET A TITER (REALLY). WARN ABOUT JARISCH-HERXHEIMER. COUNSEL NO SEX x 1 WEEK. ADVISE THAT ALL PARTNERS BE EVALUATED. CONFIRM HAS BEEN TESTED FOR HIV. ESTABLISH FOLLOW-UP EXPECTATIONS. EARLY LATE FOLLOW UP 50
51 FOLLOW UP SEROLOGIC TESTS ~Q6 MONTHS. HIV (-) HIV (+) PRIMARY / SECONDARY SYPHILIS 6, 12 MONTHS 3, 6, 9, 12, 24 MONTHS EARLY LATENT / LATE LATENT SYPHILIS 6, 12, 24 MONTHS 6, 12, 18, 24 MONTHS EARLY LATE FOLLOW UP SEROLOGIC TESTS ~Q6 MONTHS. TREATMENT RESPONSE: 4X TITER DECLINE BY 12 (P/S) OR 24 MO. 51
52 FOLLOW UP SEROLOGIC TESTS ~Q6 MONTHS. TREATMENT RESPONSE: 4X TITER DECLINE BY 12 (P/S) OR 24 MO. SUSPECTED TREATMENT FAILURE OR REINFECTION IF: 4-FOLD INCREASE IN TITERS OR NEWLY SYMPTOMATIC OR TITERS DON T DECLINE EARLY LATE FOLLOW UP SEROLOGIC TESTS ~Q6 MONTHS. TREATMENT RESPONSE: 4X TITER DECLINE BY 12 (P/S) OR 24 MO. SUSPECTED TREATMENT FAILURE OR REINFECTION IF: 4-FOLD INCREASE IN TITERS OR NEWLY SYMPTOMATIC OR TITERS DON T DECLINE NEW HIV TEST? LP for CSF VDRL? RETREAT (BICILLIN x3) 52
53 53
54 DATA DATA PARTNERS 54
55 DATA PARTNERS POLICY DATA PARTNERS POLICY ANSWERS 55
56 DATA PARTNERS POLICY ANSWERS DATA PARTNERS POLICY ANSWERS CALL PUBLIC HEALTH 56
57 . EARLY LATE. 57
58 ACKNOWLEDGEMENTS Joseph Engelman Kristen Herrick Susan Robinson Stephanie Cohen Laura Dalton Paul Bloomquist CAPTC Roxanne Ereth Rebecca Scranton Tymeckia Kendall Don Herrington 58
59 EXTRA SLIDES 59
60 Rac Syphilis in Pregnancy OB GYN 60
61 61
62 STAGE STARTS LASTS (untreated) Other sxs Infectivity Primary 10d 12 weeks after inoculation (median time 21 d) Secondary 2 8 weeks after chancre heals or 4 8 weeks after onset of chancre can overlap with 1ary Early Latent After resolution of 2ary symptoms 1 6 weeks Papule >Chancre Nontender regional adenopathy Several weeks symmetric, bilateral rash mucous patches/condyloma lata fever, headache, pharyngitis hepatitis, osteitis, glomerulonephritis meningitis/ocular/oto Until 1 year after inoculation can alternate with 2ary Late Latent 1 year after inoculation Until treatment or development of late symptomatic disease Late Symptomatic years after inoculation Neurologic: meningitis, ocular, oto, meningovascular (strokes) Until treatment General paresis (CNS parenchyma) Tabes dorsalis (posterior columns: sensory/proprio) Cardiac (aortitis, infarction) Late benign (gummatous) Infectious by direct contact or blood Infectious by direct contact (when mucosal lesions present) or blood Infectious by direct contact (when mucosal lesions present) or blood Infectious by blood Ghanem. CNS Neuroscience & Therapeutics 2010;6(5): e
63 Know syphilis in all its manifestations and relations, and all other things clinical will be added unto you. William Osler, 1909 Syphilis remains the despair of the statistician. -- William Osler, 1917 When it comes to syphilis, suspect your grandmother William Osler The souls of infants born only to die or suffer, cry out against the infamy of uncured syphilis. (well known venereal syphilologist) With our present appropriations, Federal and State and private, we might just as well try to empty the Pacific Ocean with a teaspoon. Dr. OC Wenger,
SYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM
SYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: Clinical Description (CDC 2014) Syphilis 180 days Syphilis is a complex sexually transmitted disease that
Learning Objectives. Syphilis. Lessons. Epidemiology: Disease in the U.S. Syphilis Definition. Transmission. Treponema pallidum
Learning Objectives Syphilis Treponema pallidum 1 Upon completion of this content, the learner will be able to 1. Describe the epidemiology of syphilis in the U.S. 2. Describe the pathogenesis of T. pallidum.
Syphilis Update. roadmap
AND Nurse Practitioners!!! AND Physician Assistants!!! Oliver Bacon, MD, MPH Physician, SF City Clinic Disease Prevention and Control Branch Population Health Division roadmap 1. Syphilis: diagnosis and
Syphilis Technical Instructions for Civil Surgeons
National Center for Emerging and Zoonotic Infectious Diseases Syphilis Technical Instructions for Civil Surgeons Joanna J. Regan, MD, MPH, FAAP Medical Officer Medical Assessment and Policy Team Immigrant,
Replaces: 04/13/17. / Formulated: 7/05 SYPHLIS
Effective Date: 81017 Replaces: 041317 Page 1 of 7 POLICY: The Texas Department of Criminal Justice (TDCJ) will identify, test, and manage all offenders with suspected or confirmed syphilis with a uniform
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, San Diego, CA February
Syphilis Treatment Protocol
STD, HIV, AND TB SECTION Syphilis Treatment Protocol CLINICAL GUIDANCE FOR PRIMARY AND SECONDARY SYPHILIS AND LATENT SYPHILIS www.lekarzol.com (4/2016) Page 1 of 8 Table of Contents Description... 3 Stages
Learning Objectives. Epidemiology 5/3/2013. Treponema pallidum Diagnosis, Treatment and Prevention. Anne Rompalo, MD, ScM Professor of Medicine
Treponema pallidum Diagnosis, Treatment and Prevention Anne Rompalo, MD, ScM Professor of Medicine Learning Objectives Describe the epidemiology of syphilis in the U.S.Describe the pathogenesis of Treponema
Didactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH
Didactic Series STD Screening & Management: Syphilis Christian B. Ramers, MD, MPH Assistant Medical Director Family Health Centers of San Diego Ciaccio Memorial Clinic 3/26/15 ACCREDITATION STATEMENT:
Sexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers
SYPHILIS. The Great Pretender K. Amen Eguakun, MSN, APRN, AAHIVS
SYPHILIS The Great Pretender K. Amen Eguakun, MSN, APRN, AAHIVS Learning Objectives At the end of this presentation, the participants will be able to 1. Describe the epidemiology of syphilis in the United
Syphilis Update: New Presentations of an Old Disease
Syphilis Update: New Presentations of an Old Disease Bradley Stoner, MD, PhD Washington University in St. Louis Disclosure: Bradley Stoner, MD, PhD STDs in the United States Where do we stand right now?
The Great Imitator Revealed: Syphilis
The Great Imitator Revealed: Syphilis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles David Geffen School of Medicine Los Angeles, California Learning
Public/Private Partnerships: Intervening in the Spread of Syphilis
Public/Private Partnerships: Intervening in the Spread of Diana Torres-Burgos MD, MPH Gerard Castaneda, BSN Alana Thomas, BS STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline overview Stages
Revisions to the Syphilis Surveillance Case Definitions, 2018
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Revisions to the Syphilis Surveillance Case Definitions, 2018 Sarah Kidd, MD, MPH Medical Epidemiologist Division of STD Prevention
Use of Treponemal Immunoassays for Screening and Diagnosis of Syphilis
Use of Treponemal Immunoassays for Screening and Diagnosis of Syphilis Guidance for Medical Providers and Laboratories in California These guidelines were developed by the California Department of Public
5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance. Syphilis in Men
Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance Syphilis in Men Kenneth A. Katz, MD, MSc, MSCE Kaiser Permanente, San Francisco, CA AAD Annual Meeting Washington, D.C. March 2, 2019
Management of Syphilis in Patients with HIV
Management of Syphilis in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS
9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before
George Walton, MPH, CPH, MLS(ASCP) CM STD Program Manager Bureau of HIV, STD, and Hepatitis September 15, 2015 1 1) Discuss the changing epidemiology of syphilis in Iowa; 2) Explore key populations affected
WHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
Neurosyphilis as an Emerging Feature in the HIV Setting. Christina M. Marra, MD University of Washington Seattle, WA, USA
Neurosyphilis as an Emerging Feature in the HIV Setting Christina M. Marra, MD University of Washington Seattle, WA, USA Syphilis in the Developing World Region 1995 1999 Sub-Saharan 3,530,000 3,828,000
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, Orlando, FL March 4, 2017
The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia Lara E. Pereira, Ph.D. Centers
To view an archived recording of this presentation please click the following link:
To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/p16lj8z0qm3/ Please scroll down this file to view a copy of the slides from the session.
SYPHILIS (REPORTABLE)
SYPHILIS (REPORTABLE) PREAMBLE In BC, the diagnosis of syphilis is determined by the BCCDC Provincial STI/HIV Clinic physician directly or in coordination with the*physician or nurse practitioner (NP)
Syphilis Update. Dr. Bauer has no disclosures. STD Clinical Update San Diego California Prevention Training Center October 11, 2018
Heidi M. Bauer, MD MS MPH Chief, STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center San Diego Dr. Bauer has no disclosures 1 Learning Objectives 1.
10/19/2012. Serologic Testing for Syphilis. Disclosures. Comparison of the Traditional and Reverse Screening Algorithms. Outline.
Serologic Testing for Syphilis Comparison of the Traditional and Reverse Screening Algorithms Disclosures Elli S. Theel, Ph.D. Director, Infectious Diseases Serology Laboratory Assistant Professor of Laboratory
CHAPTER-X SYPHILIS R.KAVITHA, M.PHARM, LECTURER, DEPARTMENT OF PHARMACEUTICS, SRM COLLEGE OF PHARMACY, SRM UNIVERSITY, KATTANKULATHUR.
CHAPTER-X SYPHILIS R.KAVITHA, M.PHARM, LECTURER, DEPARTMENT OF PHARMACEUTICS, SRM COLLEGE OF PHARMACY, SRM UNIVERSITY, KATTANKULATHUR. Trepanoma pallidum D. Clinical Infection: Syphilis Transmission Usually
Dr Edward Coughlan. Clinical Director Christchurch Sexual Health
Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch Sexual Health 33 St Asaph Street Dr Edward Coughlan Clinical Director Why this Work Shop on Syphilis? Because it is here Very
Syphilis among MSM: Clinical Care and Public Health Reporting
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Syphilis among MSM: Clinical Care and Public Health Reporting Kevin Ard, MD, MPH, Medical Director, National
Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections?
Abstract no. WEPE 494 Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections? G.Chrysos 1, D.Karageorgopoulos
MID 15. Syphilis. Simon Tsiouris, MD, MPH. 1. Introduction
Syphilis Simon Tsiouris, MD, MPH 1. Introduction Syphilis is a chronic infection caused by the bacterium Treponema pallidum which was first described over 500 years ago. The manifestations of disease are
Validation of a New Testing Algorithm for Syphilis in Trinidad & Tobago
Validation of a New Testing Algorithm for Syphilis in Trinidad & Tobago R. Dass, A. Sebro, J. Edwards Ministry of Health, Trinidad and Tobago rianna.dass@hotmail.com, asebro@yahoo.com, jeffreye2000@gmail.com
Syphilis Testing in Northern California Kaiser
Syphilis Testing in Northern California Kaiser Jen Shieh, MS, CLS Test Development Scientist Kaiser Permanente TPMG Regional Laboratory Microbiology Department Kaiser Permanente 3.3 million members 22
Nothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
2/13/ Graphic photographs or cartoons used during this presentation might be offensive to some; for this I apologize in advance.
Leon Bullard, MD, MA Medical Consultant, DHEC, DADE The 23 rd Annual APRN Conference Charleston, SC February 24, 2017 1. Provide a brief (very) review of the syphilis story. 2. Define and discuss the stages
Clinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
26. Screening for Syphilis
26. Screening for Syphilis RECOMMENDATION Routine serologic screening for syphilis is recommended for all pregnant women and for persons at increased risk of infection (see Clinical Inter - vention). See
SEXUALLY TRANSMITED DISEASES SYPHILIS ( LUES ) Dr D. Tenea Department of Dermatology University of Pretoria
SEXUALLY TRANSMITED DISEASES SYPHILIS ( LUES ) Dr D. Tenea Department of Dermatology University of Pretoria INTRODUCTION Venereal disease = old term STD infections transmitted by sexual contact Sexually
January Dear Physician:
Richard F. Daines, M.D. Commissioner Wendy E. Saunders Executive Deputy Commissioner January 2009 Dear Physician: The purpose of this letter is to bring your attention to the significant increase in reported
Annual Epidemiological Report
Annual Epidemiological Report November 2018 Key Facts 1 Early infectious syphilis in Ireland, 2017 There were 398 confirmed cases of early infectious syphilis (EIS) notified in 2017 The notification rate
Spirochetes. Treponema pallidum
Spirochetes Treponema pallidum Dr. Hala Al Daghistani - Spirochetes are a large, heterogeneous group of spiral, motile bacteria. - One family Spirochaetaceae consists of two genera whose members are human
Management of infants at risk of congenital syphilis
Management of infants at risk of congenital syphilis Version: Issued: Review date: Author: Dr Sanjay Patel (Paediatric Infectious Diseases Consultant), Dr Emanuela Pelosi (Consultant Virologist), Dr Mildred
4/18/2018. Syphilis Testing. Disclosure. Learner Objectives. Outline. Employee and stockholder of Bio-Rad Laboratories, Inc.
Disclosure Employee and stockholder of Bio-Rad Laboratories, Inc. Unraveling the Complexities of Syphilis Testing Maria Crisostomo, April 30 & May 1, 2018 2 Learner Objectives Syphilis Testing Upon completion
NIH Public Access Author Manuscript Clin Infect Dis. Author manuscript; available in PMC 2009 October 1.
NIH Public Access Author Manuscript Published in final edited form as: Clin Infect Dis. 2008 October 1; 47(7): 893 899. doi:10.1086/591534. Normalization of Serum Rapid Plasma Reagin Titer Predicts Normalization
Emerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
Syphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response?
The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response? Gillian Hill-Carroll Travis Salway Hottes Pacific AIDS Network Webinar Series
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory
Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory Describe the challenges in syphilis diagnostics Present two testing algorithms Non-treponemal test as initial screen Treponemal
12/1/2014 GLOBAL HEALTH CASE STUDY RACHEL LE HISTORY OF PRESENT ILLNESS ANY IDEAS? Location: Vadodara, India Gender: female
GLOBAL HEALTH CASE STUDY RACHEL LE HISTORY OF PRESENT ILLNESS Location: Vadodara, India Gender: female Age: 14 years Complains: perforation, anterior hard palate, difficulty eating, difficulty speaking
Current standards for diagnosis and treatment of syphilis: selection of some practical issues, based on the European (IUSTI) and U.S.
Special paper Current standards for diagnosis and treatment of syphilis: selection of some practical issues, based on the European (IUSTI) and U.S. (CDC) guidelines Maciej Pastuszczak, Anna Wojas-Pelc
Syphilis MID yo man is seen at an STD clinic for a painless ulcer on his penis
Syphilis Simon J. Tsiouris, MD, MPH Assistant Professor of Clinical Medicine and Clinical Epidemiology Division of Infectious Diseases College of Physicians and Surgeons Columbia University 43 yo woman
Profile of Syphilis. By Karley Delahoussaye
Profile of Syphilis By Karley Delahoussaye Etiologic Agent: Treponema pallidum₁ Transmission: People transmit syphilis to each other directly through contact with a sore. The sores are known as chancres
Bacteriology. Spirochetes. Three important genera: 1. Treponema 2. Borrelia 3. Leptospira. Treponema pallidum. Causes syphilis.
Bacteriology Spirochetes Three important genera: 1. Treponema 2. Borrelia 3. Leptospira Treponema pallidum Causes syphilis Organism: - Spirochetes with 6-14 regularly spaced spirals - Its length is the
Syphilis Screening and Prevalence: Past, Present, Future
Syphilis Screening and Prevalence: Past, Present, Future Allison Haynes, MD University of Kansas School of Medicine- Wichita Family Medicine Residency at Smoky Hill- Salina 1 https://www.cdc.gov/std/syphilis/images/treponema-pallidum.htm
Direct Comparison of the Traditional and Reverse Syphilis Screening Algorithms
JCM Accepts, published online ahead of print on 16 November 2011 J. Clin. Microbiol. doi:10.1128/jcm.05636-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
EPIDEMIC OF SYPHILIS
Brian Sandoval Governor Richard Whitley, MS Director Julie Kotchevar, PhD Administrator Ihsan Azzam, PhD, Md Chief Medical Officer EPIDEMIC OF SYPHILIS Understanding the Clinical & Public Health Need for
Annals of Internal Medicine. 1991;114:
Serologic Response to Treatment of Infectious Syphilis Barbara Romanowski, MD; Ruth Sutherland, DPH, RN; Gordon H. Fick, PhD; Debbie Mooney, BSc; and Edgar J. Love, MD, PhD Objective: To evaluate the serologic
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
Using Mathematical Models to Inform Syphilis Control Strategies in Men Who Have Sex With Men
Using Mathematical Models to Inform Syphilis Control Strategies in Men Who Have Sex With Men by Ashleigh Tuite A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy
Division of Dermatology Dr A Motau
Division of Dermatology Dr A Motau CASE 1 Histopathology H&E H&E H&E Wartin Starry Immunohistochemical stain for T. pallidum Investigations FBC, U&E, LFT Normal T. pallidum Abs Reactive RPR screen
Sharon Adler M.D., M.P.H. California Prevention Training Center Assistant Clinical Professor UCSF FCM
Sharon Adler M.D., M.P.H. California Prevention Training Center Assistant Clinical Professor UCSF FCM Sharon Adler MD, MPH has no relevant financial relationships with an entity producing, marketing, re
STDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
Another New HIV Diagnosis
Another New HIV Diagnosis P. Young, RPAC Shelley A Gilroy, MD Albany Medical College June 3, 2014 The Patient 21-year-old male college student with rash x 1 month, beginning on his face Non-tender & non-pruritic
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
Syphilis New spread of an old disease. Erika Vlieghe STD/HIV unit
Syphilis New spread of an old disease Erika Vlieghe STD/HIV unit Institute of Tropical Medicine, Antwerp 1. Epidemiology 3 waves of syphilis in 20th century: 1. Post-world war II: mainly heterosexual
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
Sexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP
Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]
The U.S. Preventive Services Task Force (USPSTF) makes
Annals of Internal Medicine Clinical Guidelines Screening for Syphilis Infection in Pregnancy: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement U.S. Preventive Services Task Force*
A Man with a Rash and Pink Eye. STD Case Studies from the Denver Metro Health Clinic
A Man with a Rash and Pink Eye STD Case Studies from the Denver Metro Health Clinic Case 45 year-old HIV+ gay male, presented to the STD clinic as a contact to gonorrhea Generalized rash since 6 weeks
Re-emerging infections: Syphilis & Tuberculosis
Re-emerging infections: Syphilis & Tuberculosis Nicholas Jones Manchester Royal Eye Hospital Syphilis and TB - historical plagues? Syphilis incidence over 40yrs Manchester: Manchester: The Syphilis Capital
ANNUAL MORBIDITY REPORT
DUTCHESS COUNTY DEPARTMENT OF HEALTH S ANNUAL MORBIDITY REPORT Marcus J. Molinaro, Dutchess County Executive Kari Reiber, MD, Acting Commissioner of Health Volume 8, Issue FIRST CONGENITAL SYPHILIS CASE
Edward W. Hook, III, M.D.
Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research
Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
Evaluation of Reagin Screen, a New Serological Test for Syphilis
JOURNAL OF CUNICAL MICROBIOLoGY, Aug. 1976, p. 145-150 Copyright 1976 American Society for Microbiology Vol. 4, No. 2 Printed in U.S.A. Evaluation of Reagin Screen, a New Serological Test for Syphilis
Interpreting Syphilis Serology
Interpreting Syphilis Serology Dr Beng Goh Royal London Hospital Barts & The London NHS Trust beng.goh@bartsandthelondon.nhs.uk Serological Tests for Syphilis: Principles Screening Confirmation Staging
BURNING & SQUIRMING WHAT S NEW IN SEXUALLY TRANSMITTED INFECTIONS
BURNING & SQUIRMING WHAT S NEW IN SEXUALLY TRANSMITTED INFECTIONS Dr. Joss Reimer MD MPH FRCPC Medical Officer of Health, WRHA & Manitoba Health Assistant Professor, Departments of Community Health Sciences
Sexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
CATIE Webinar Series (Part 1) Gay Men s Health & HIV Prevention in Canada
CATIE Webinar Series (Part 1) Gay Men s Health & HIV Prevention in Canada The Rising Tide of Syphilis: Update on Syphilis among Gay, Bisexual, Two-Spirit and other MSM in Canada Wednesday, February 22nd,
Chapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
VDRL v/s TPHA for diagnosis of syphilis among HIV sero-reactive patients in a tertiary care hospital
ISSN: 2319-7706 Volume 3 Number 5 (2014) pp. 726-730 http://www.ijcmas.com Original Research Article VDRL v/s TPHA for diagnosis of syphilis among HIV sero-reactive patients in a tertiary care hospital
* Proposed new case definition; to be confirmed by AFHSC following analyses of data
1 ID 13 * Proposed new case definition; to be confirmed by AFHSC following analyses of data SYPHILIS Includes Early Syphilis (Primary, Secondary, Early Latent) and Late Syphilis (Tertiary, Late Latent);
Syphilis: Management Challenges
Syphilis: Management Challenges Khalil Ghanem & Susan Tuddenham Johns Hopkins University School of Medicine Baltimore, MD USA uwptc@uw.edu uwptc.org 206-685-9850 Patient 1 36 year old gay man with sudden
Case 1. Case 1. Physical exam
11/13/2012 Case 28 year-old woman Complains of very painful lesions in vulvar area Increasing severity since 4 days Pain aggravated by urination She has a slight fever and also complains of headache and
1.4.5 SYPHILIS IN PREGNANCY AND THE NEWBORN DIAGNOSIS AND TREATMENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION B : GUIDELINES RELEVANT TO OBSTETRICS & MIDWIFERY 1 ANTEPARTUM CARE 1.4 INFECTIONS IN PREGNANCY Authorised by: OGCCU and the Newborn. 1.4.5
Medical Bacteriology Lecture 11
Medical Bacteriology Lecture 11 Spirochaetaceae Treponema Borrelia 1 Spirochaetaceae Characteristics - Gran negative rods - spiral single cells, or cork-screw-shaped, extremely thin and can be very long
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
Syphilis Screening in the Community
Syphilis Screening in the Community A NJ DOH DHSTS Pilot Project Eugene G. Martin, Ph.D Co-Director, NJ HIV Professor of Pathology and Laboratory Medicine Rutgers University Robert Wood Johnson Medical
Danger Between the Sheets: Life Threatening Complications of STI's
Danger Between the Sheets: Life Threatening Complications of STI's Ryan Misek, DO, FACOEP, FACEP Clinical Associate Professor Course Director of Emergency Medicine Core Faculty, Emergency Medicine Residency
Sexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
IUSTI Europe Conference on STI Mykonos, Greece, October 7-9, 2004
IUSTI Europe Conference on STI Mykonos, Greece, October 7-9, 2004 IUSTI/WHO Europe Workshop on Management of Syphilis: 6 scientific background papers 1 Editor: P.C. van Voorst Vader, Dept of Dermatology,
This study was undertaken to assess the value
Syphilis Detection in Cerebrovascular Disease Roger E. Kelley, MD, Lynda Bell, RN, Susan E. Kelley, RN, and Shih-Chang Lee, PhD To determine the importance of syphilis testing in cerebrovascular disease,
Clinical Reasoning: The Great Imitator
RESIDENT & FELLOW SECTION Section Editor Mitchell S.V. Elkind, MD, MS Clinical Reasoning: The Great Imitator Nazia Karsan, MRCP Robert Barker, FRCR John Philip O Dwyer, MD Correspondence to Dr. Karsan: